Abstract Submission

The deadline to submit abstracts is now closed.

Thank you for your submissions

General Information & Deadlines

  1. Abstracts submission deadline is now closed. They were required to be submitted electronically via the online submission system by 6 February 2018. Abstracts received via fax, e-mail or received after the deadline will not be accepted and therefore will not be considered for the program or publication.
  2. Abstracts may be submitted for the following categories and scientific topics:

Clinical (8 Topics)

  • CNS/Base of Skull/Eye
  • Pediatrics
  • Breast
  • Lung
  • GI
  • GU
  • Sarcoma/Lymphoma
  • Head and Neck

Physics: (10 Topics)

  • Beam Delivery and Nozzle Design
  • Accepting and Commissioning New Facilities
  • Absolute and Relative Dosimetry
  • Quality Assurance
  • Treatment Planning
  • Dose Calculation and Optimisation
  • Image Guidance and IGPT
  • Monitoring and Modeling Motion
  • 4D Treatment and Delivery
  • Adaptive Therapy

Biology: (5 Topics)

  • Biological Differences Between Carbon, Proton and Photons Effects at the Molecular, Cellular and System Levels
  • Biological Optimization (Combined Therapies, Molecular Targeting)
  • Biomarkers for:
    • Patient Selection for Proton, Carbon or Photon Treatment
    • Immune Responses
    • Adverse Normal Tissue Response Biomarkers
    • Therapeutic Response
    • Disease Recurrence
    • Molecular Imaging
    • Biological Modeling
    • Translational Research Models (In Vivo and In Vitro (3D))

During the submission process all submissions must include either of the following two preferred presentation methods:

  • Oral Presentation
  • Poster Presentation

CME credit will be available for PTCOG 57. Therefore, all presenting and co-authors attached to a submitted abstract must complete a CME disclosure for the abstract to be considered for oral presentation. All authors will receive an email once submission is completed including instructions as to how to complete the disclosure. Make sure you read the terms and conditions within the CME disclosure.

PTCOG is proud to invite PTCOG members to apply for the PTCOG Young Investigator Award. To be considered for a ‘Young Investigator Award‘ please select the ‘Young Investigator Award‘ option during abstract submission. Candidates for this award must meet all of the following criteria:

  • Completed terminal research degree or end of post-graduate clinical training, whichever date is later, within the past 5 years.
  • A rank up to and including Assistant Professor, if applicable.
  • Previously not been awarded a Young Investigator Award from PTCOG.

All authors will be asked to indicate whether his/her work relates to cost effectiveness. As the accessibility to Particle Therapy around the world increases, growth is still restrained by the perception of the higher initial capital and operational costs of this modality leading to higher patient costs, compared to other treatment modalities. It has become one of the important missions of PTCOG to either dispel this perception (if appropriate) or to identify ways to reduce overall costs and increase treatment efficiency in order to decrease the cost to the patient. Therefore, PTCOG will pay special attention to submitted abstracts that address aspects of the cost effectiveness of particle therapy including improvement thereof.

Cost effectiveness can have many factors, but need not all be included in a single submission; the submission must have one or more important relevant elements, such as:

    • Reduced treatment cost coming from reduced capital costs for particle therapy facilities (protons or heavier ions).
    • Reduced operational costs and/or improved treatment efficiency.
    • Reduced of the overall lifetime costs of treatment care for a patient; e.g., a reduction of side effects can reduce the overall healthcare costs for a patient.

The abstract deadline is now closed. They MUST have been submitted electronically via the online submission system by the deadline, 6 February 2018. Abstracts received via fax, e-mail or received after the deadline will not be accepted and therefore will not be considered for the program or publication.

Abstracts can be amended in the online submission system if saved as a draft (through the “Save as draft” button) prior to the submission deadline of 4 January 2018. Once the abstract is “submitted” (through the “submit” button) it can no longer be changed unless requested in writing to the PTCOG 57 Secretariat by clicking the following link PTCOG57 Secretariat.

All abstracts will be reviewed by the PTCOG Scientific Program Sub-Committee, who will consider its formal aspects and content. The Sub-Committee will decide which abstracts will be accepted and may reconsider the final presentation type.

Accepted abstracts will be made available electronically to all conference attendees. Rejected abstracts will not be displayed or published. Please have your abstract checked for correct spelling, punctuation, grammar and formal structure. PTCOG reserves the right to edit abstracts if necessary prior to the publication in the PTCOG Website or Journal.

All presenting authors of abstracts selected for an oral or poster presentation will be notified by 9 March 2018.

All presenting authors and poster presenters are obliged to register for the PTCOG 57 Scientific Session by 22 March 2018.

English is the official language of PTCOG 57. As such, all abstracts must be written in English, all presentations must be in English and all posters must be in English.

When submitting your abstract, consider and choose the appropriate category, scientific topic and the presentation method.

The abstract title is limited by 20 words and must be submitted using the sentence case (e.g. This is the title of my abstract).
Up to 10 authors can be submitted for an abstract (including the presenting author). The presenting author is selected first; other authors can be added only when the presenting author is submitted. However, the author order can be changed if needed by swapping the names in the list of the authors. The first name is always considered to be the main author.

The maximum abstract length is 250 words.

Up to 2 pictures/charts/tables can be included within the abstract text. (Please check the step-by-step picture upload guide below.)

Pictures must be saved in .jpg

Charts can only be inserted as a picture (saved as .jpg first)

Tables can only be inserted as a picture (saved as .jpg first)
The number of submitted abstracts per one submitter/author is not limited.

Up to two pictures (see 1 in the following slide) can be inserted within the abstract text using the picture insert icon. They must be saved in JPG.

1. Place the picture title within the abstract in the location where the picture should appear (see 2 in slide below). Click the “Picture Insert” icon to start the upload process (see 3 in slide below).


2. Click the “Upload” button (see 1 in slide below) and select the picture you wish to insert from your computer. It will be uploaded to the insert image gallery (see 2 in slide below).


3. Select the corresponding picture (see 1 in slide below), copy the picture title into the “Alternate Text” field (see 2 in slide below) and add the picture dimensions (one size is enough) (see 3 in slide below) and confirm the selection with the ”Insert” button (see 4 in slide below) (width 300px = approx. 7cm wide).


4. When the picture is uploaded, the correct location and size can be checked. If you wish to change the dimensions you can simply delete the inserted picture and upload it once again with a different size.

Please subscribe me to the PTCOG57 news list